NASDAQ:XNCR

Xencor Stock Insider Trading

etoro logo Buy XNCR
*Your capital is at risk
$14.96
-0.89 (-5.62%)
At Close: Jul 13, 2026

Xencor Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -21.08. In total, the insiders bought 2.63M and sold 313.63K XNCR shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-21.08
Buy 2.63M shares
Sell 313.63K shares
68% Buy Activity
Moderate Negative Correlation
Buy Signal Low Confidence
Mar 02, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -21.08.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jun 18, 2026
Sell
Common Stock
S-Sale
Feigal Ellen
Director
Director 6 843
Value: $89.4K
Jun 16, 2026
Buy
Stock Option (Right to Buy)
A-Award
Deshaies Raymond Joseph
Director
Director 20 604
Value: $251.4K
Jun 16, 2026
Buy
Stock Option (Right to Buy)
A-Award
Simpson Todd E
Director
Director 20 604
Value: $251.4K
Jun 16, 2026
Buy
Common Stock
A-Award
Simpson Todd E
Director
Director 10 302
Value: $125.7K
Jun 16, 2026
Buy
Stock Option (Right to Buy)
A-Award
Ranieri Richard J
Director
Director 20 604
Value: $251.4K
Jun 16, 2026
Buy
Common Stock
A-Award
Klencke Barbara
Director
Director 10 302
Value: $125.7K
Jun 16, 2026
Buy
Stock Option (Right to Buy)
A-Award
Gustafson Kurt A
Director
Director 20 604
Value: $251.4K
Jun 16, 2026
Buy
Common Stock
A-Award
Gustafson Kurt A
Director
Director 10 302
Value: $125.7K
Jun 16, 2026
Buy
Stock Option (Right to Buy)
A-Award
Gorman Kevin Charles
Director
Director 20 604
Value: $251.4K
Jun 16, 2026
Buy
Common Stock
A-Award
Gorman Kevin Charles
Director
Director 10 302
Value: $125.7K
Jun 16, 2026
Buy
Stock Option (Right to Buy)
A-Award
Feigal Ellen
Director
Director 20 604
Value: $251.4K
Jun 16, 2026
Buy
Common Stock
A-Award
Feigal Ellen
Director
Director 10 302
Value: $125.7K
Jun 16, 2026
Buy
Stock Option (Right to Buy)
A-Award
Klencke Barbara
Director
Director 20 604
Value: $251.4K
Jun 16, 2026
Buy
Common Stock
A-Award
Montgomery Alan Bruce
Director
Director 10 302
Value: $125.7K
Jun 16, 2026
Buy
Stock Option (Right to Buy)
A-Award
Montgomery Alan Bruce
Director
Director 20 604
Value: $251.4K
Jun 16, 2026
Buy
Common Stock
A-Award
Ranieri Richard J
Director
Director 10 302
Value: $125.7K
Jun 16, 2026
Buy
Common Stock
A-Award
Deshaies Raymond Joseph
Director
Director 10 302
Value: $125.7K
Jun 15, 2026
Sell
Common Stock
S-Sale
Gorman Kevin Charles
Director
Director 7 527
Value: $92.7K
Jun 15, 2026
Sell
Common Stock
S-Sale
Gustafson Kurt A
Director
Director 5 474
Value: $67.4K
Jun 15, 2026
Sell
Common Stock
S-Sale
Ranieri Richard J
Director
Director 5 474
Value: $67.4K
Jun 15, 2026
Sell
Common Stock
S-Sale
Montgomery Alan Bruce
Director
Director 5 064
Value: $62.3K
Apr 10, 2026
Sell
Common Stock
S-Sale
Cornelissen Bart Jan
Sr. Vice President & CFO
CEO / President 3 499
Value: $43.0K
Mar 06, 2026
Sell
Common Stock
S-Sale
Eckert Celia
SVP, General Counsel
Officer 1 767
Value: $19.5K
Mar 06, 2026
Sell
Common Stock
S-Sale
Desjarlais John R
Sr. Vice President & Cso
CEO / President 2 502
Value: $27.6K
Mar 06, 2026
Sell
Common Stock
S-Sale
Dahiyat Bassil I
President & CEO
CEO / President 6 606
Value: $72.8K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT XENCOR
Xencor
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome; and Monjuvi for the treatment of patients with r...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
10.58% Jun 29
NMRK
$15.02
0.466% Jun 24
X
XMAX
$8.34
2.40% Jun 24
NESR
$25.07
12.49% Jun 23
CAG
$13.43
6.70% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE